Medical Experts
Authors frame content, identify key sources of information, draft and/or critically edit and revise content to ensure medical accuracy and integrity, and review and approve content for publication.
Fisher

Pearson

Sepsis is a severe illness characterized by a systemic, whole-body response to infection and is a frequent cause of morbidity and mortality in hospitalized patients. Sepsis is most common in older individuals and infants, and can be difficult to diagnose due to its variable presentation. Because there is no confirmatory diagnostic test, sepsis diagnosis requires clinical judgment based on evidence of infection and organ dysfunction.
The clinical practice guideline issued by the Surviving Sepsis Campaign (SSC) emphasizes the importance of early identification and immediate management of infection, which includes obtaining cultures and measuring serum lactate as soon after patient presentation as possible. The SSC recently released a 1-hour bundle that combines the SSC’s previous 3-hour and 6-hour bundles and recommends beginning sepsis management and treatment immediately at the point of presentation. 1 Society of Critical Care Medicine. Surviving Sepsis Campaign bundle. Accessed Aug 2020.
Quick Answers for Clinicians
While anyone can develop sepsis, certain individuals are at higher risk, including the following 2 National Institute for Health and Care Excellence. Sepsis: recognition, diagnosis and early management. Updated Sep 2017; accessed Aug 2019.
- Adults ≥65 years
- Children ≤1 year
- Individuals with weakened immune systems
- Individuals with chronic medical conditions (eg, diabetes, cancer, lung or kidney disease)
- Those who have undergone surgery or other invasive procedures within the past 6 weeks
There is no definitive diagnostic test for sepsis. Along with clinical data, laboratory testing can provide clues that indicate the presence of or risk of developing sepsis. Serum lactate measurement may help to determine the severity of sepsis and is used to monitor therapeutic response. Peripheral blood cultures are useful for investigating the infectious etiology of sepsis and for managing appropriate antimicrobial treatment. Other tests, including CBC and chemistries, provide a baseline to assess therapeutic response.
Procalcitonin (PCT) levels provide supportive evidence that systemic inflammation is due to bacterial infection. As such, PCT testing can be useful in decreasing the unnecessary use of antibiotics. PCT levels may also be used to predict 28-day cumulative mortality risk for patients diagnosed with sepsis. A PCT concentration that has not declined by 80% or more between days 1 and 4 of admission is consistent with a higher cumulative mortality risk. 3 Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34(4):263-273. Schuetz P, Birkhahn R, Sherwin R, et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study. Crit Care Med. 2017;45(5):781-789.
Indications for Testing
Individuals with one or more risk factors and relevant clinical presentation (eg, possible source of infection and systemic signs of inflammation or organ dysfunction) should be screened for sepsis.
Clinical Definition
Sepsis
Sepsis was redefined in the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) as “life threatening organ dysfunction caused by dysregulated host response to infections.” 5 Singer M, Deutschman CS, Seymour CWarren, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. Singer M, Deutschman CS, Seymour CWarren, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. Singer M, Deutschman CS, Seymour CWarren, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. American College of Emergency Physicians. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. Accessed Sep 2022.
Adult patients outside of intensive care units (ICUs) (ie, in the inpatient or outpatient setting) with suspected infection are at risk of sepsis development if they meet two or more quick SOFA (qSOFA) Score criteria. 5 Singer M, Deutschman CS, Seymour CWarren, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
Septic Shock
Septic shock is a subset of sepsis characterized by circulatory, cellular, and metabolic abnormalities that are associated with a greater risk of mortality than sepsis alone. Septic shock can be identified by the presence of sepsis in addition to the following 5 Singer M, Deutschman CS, Seymour CWarren, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
- Persistent hypotension requiring vasopressors to maintain mean arterial pressure of ≥65 mmHg
- Serum lactate level of >2 mmol/L in the absence of hypovolemia
Laboratory Testing
Initial Workup for Suspected Sepsis
Although there is no definitive confirmatory diagnostic test for sepsis, the following laboratory tests can help assess organ dysfunction and contribute to the clinical diagnosis and appropriate medical management of sepsis.
Serum Lactate
Sepsis-induced hypoperfusion may manifest with acute organ dysfunction and/or decreased blood pressure and increased serum lactate. Lactate >2 mmol/L is considered abnormal and levels >4 mmol/L often suggest occult hypoperfusion and should trigger resuscitation. 6 American College of Emergency Physicians. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. Accessed Sep 2022. American College of Emergency Physicians. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. Accessed Sep 2022. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-377.
Blood Culture
Two sets of blood cultures (aerobic and anaerobic) should be obtained from two different sites before administering antibiotics to ensure accurate identification of pathogens and proper medical management of infection. 1 Society of Critical Care Medicine. Surviving Sepsis Campaign bundle. Accessed Aug 2020.
Procalcitonin
Procalcitonin (PCT) is an acute phase reactant that is used as a biomarker for the diagnosis of sepsis and as a guide for antibiotic stewardship. 4 Schuetz P, Birkhahn R, Sherwin R, et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study. Crit Care Med. 2017;45(5):781-789. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-377.
C-Reactive Protein
C-reactive protein (CRP) is a nonspecific marker of acute inflammation. CRP does not peak for up to 48 hours after the onset of sepsis and its concentration does not correlate with sepsis severity or prognosis. However, there is good evidence that the use of CRP testing may help rule out neonatal sepsis in full-term infants. Recent studies suggest similar efficacy in preterm infants.
Other Testing
CBC, bilirubin, and creatinine tests are also used in calculating SOFA scores and may help identify patients with sepsis. 5 Singer M, Deutschman CS, Seymour CWarren, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
Monitoring
Serum Lactate
Lactate levels >2 mmol/L should be remeasured within 2-4 hours to guide resuscitation and normalization of lactate. 1 Society of Critical Care Medicine. Surviving Sepsis Campaign bundle. Accessed Aug 2020. American College of Emergency Physicians. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. Accessed Sep 2022.
Procalcitonin
The SSC suggests that PCT measurements can be used to support shortening the duration of antimicrobial therapy in some patients with sepsis, such as those with bacterial pneumonia or lower respiratory tract infections. 7 Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-377.
PCT measurements also provide supportive evidence that systemic inflammation is due to bacterial infection and can be used to predict 28-day cumulative mortality risk for patients diagnosed with sepsis. Decreased PCT levels are independent predictors of mortality in patients with sepsis. The multicenter Procalcitonin Monitoring Sepsis (MOSES) study found that a PCT concentration that has not declined by 80% or more between days 1 and 4 of admission is consistent with a higher cumulative mortality risk. 3 Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34(4):263-273. Schuetz P, Birkhahn R, Sherwin R, et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study. Crit Care Med. 2017;45(5):781-789.
ARUP Laboratory Tests
Enzymatic Assay
Quantitative Electrochemiluminescent Immunoassay (ECLIA)
Quantitative Immunoturbidimetry
Stain/Culture/Identification
Quantitative Ion-Selective Electrode/Quantitative Enzymatic Assay/Quantitative Spectrophotometry
References
-
Surviving Sepsis Campaign Bundle: 2018 Update
Society of Critical Care Medicine. Surviving Sepsis Campaign bundle. Accessed Aug 2020.
-
NIHCE - Sepsis
National Institute for Health and Care Excellence. Sepsis: recognition, diagnosis and early management. Updated Sep 2017; accessed Aug 2019.
-
24982830
Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34(4):263-273.
-
28257335
Schuetz P, Birkhahn R, Sherwin R, et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study. Crit Care Med. 2017;45(5):781-789.
-
26903338
Singer M, Deutschman CS, Seymour CWarren, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
-
ACEP - DART: An evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock
American College of Emergency Physicians. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. Accessed Sep 2022.
-
28101605
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-377.